Page 5 - Nasdaq Tcon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) and REGENXBIO (NASDAQ:RGNX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 40.2% of TRACON Pharmaceuticals […]

StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on the stock. Jonestrading reissued a hold rating on shares of TRACON Pharmaceuticals in a research […]

StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report issued on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts also recently commented on the stock. Robert W. Baird dropped their price target on shares of TRACON Pharmaceuticals from $7.00 to […]

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Free Report) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 355,200 shares, a decline of 27.5% from the September 15th total of 489,600 shares. Based on an average trading volume of 548,400 shares, […]

StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report released on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. TCON has been the topic of a number of other reports. Jonestrading restated a hold rating on shares of TRACON Pharmaceuticals in a research note on […]